|Bid||37.50 x 2200|
|Ask||37.87 x 1800|
|Day's Range||37.18 - 37.67|
|52 Week Range||33.78 - 63.10|
|Beta (5Y Monthly)||0.92|
|PE Ratio (TTM)||22.28|
|Earnings Date||Aug 15, 2022 - Aug 19, 2022|
|Forward Dividend & Yield||0.50 (1.35%)|
|Ex-Dividend Date||Sep 29, 2022|
|1y Target Est||42.70|
Subscribe to Yahoo Finance Plus to view Fair Value for XRAY
Dentsply Sirona says its internal investigation into financial-reporting irregularities has expanded. The company warns that preliminary quarterly results released in May will have to be corrected and that 2021 financials may have to be restated.
DENTSPLY SIRONA's (XRAY) preliminary second-quarter 2022 results reflect the normalizing business, aided by product launches and pricing adjustments. Shares rise.
Dentsply Sirona Inc (NASDAQ: XRAY) expects to report Q2 FY22 net sales of over $1.01 billion. Additionally, diluted EPS is expected to be at or above $0.26 and adjusted EPS at or above $0.60. The company said that though sales declined Y/Y due to the unfavorable impact of foreign exchange, the business delivered organic sales growth driven by solid European regional performance and demand in CAD/CAM, Equipment & Instruments, and Restorative and Preventive Consumables. The company continued to ex